EFFECT OF CENTRALLY-ACTING DRUGS ON MOBILIZATION OF FREE FATTY ACIDS.
D002491:Central Nervous System Agents; D002746:Chlorpromazine; D003891:Desipramine; D005227:Fatty Acids / Q000378:metabolism*; D005230:Fatty Acids, Nonesterified; D006213:Hallucinogens; D007099:Imipramine; D007211:Indoles; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood*; D008238:Lysergic Acid Diethylamide; D008635:Mescaline; D010600:Pharmacology; D011562:Psilocybin; D012110:Reserpine; D013881:Thioridazine; D014149:Tranquilizing Agents
D002491:Central Nervous System Agents; D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; D006213:Hallucinogens; D007211:Indoles; D008055:Lipids; D014149:Tranquilizing Agents; D011562:Psilocybin; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D013881:Thioridazine; D007099:Imipramine; D008635:Mescaline; D003891:Desipramine; D002746:Chlorpromazine
BLOOD LIPIDS; CHLORPROMAZINE; DESIPRAMINE; FATTY ACID METABOLISM; HALLUCINOGENS; IMIPRAMINE; INDOLES; LYSERGIC ACID DIETHYLAMIDE; MESCALINE; PHARMACOLOGY; PSILOCYBINE; RESERPINE; THIORIDAZINE; TRANQUILIZING AGENTS